|
"tien feng ming"的相關文件
顯示項目 1-10 / 40 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-04-26T08:24:46Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien, Feng-Ming; Tsai, Cheng-Hong; Huang, Sheng-Chuan; Liu, Jia-Hau; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; WEN-CHIEN CHOU; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-04-26T08:21:05Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; Tien, Feng-Ming; Liu, Jia-Hau; WEN-CHIEN CHOU; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; Lin, Yun-Chu; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-04-14T06:18:05Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; Tien Feng-Ming; Liu Jia-Hau; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; YUN-CHU LIN; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; Ming Yao |
| 臺大學術典藏 |
2022-03-04T03:55:35Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-03-04T03:52:50Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; SHANG-JU WU; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-01-25T05:32:21Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-25T01:29:00Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; HWEI-FANG TIEN |
| 臺大學術典藏 |
2022-01-12T08:28:38Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Chieh-Lung Cheng; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-01-10T09:11:05Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-01-10T08:54:12Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
CHENG-HONG TSAI; JIH-LUH TANG; Tien, Feng Ming; YUAN-YEH KUO; Wu, Dung Chi; CHIEN-CHIN LIN; Tseng, Mei Hsuan; Peng, Yen Ling; Hou, Mei Fang; Chuang, Yi Kuang; Liu, Ming Chih; CHIA-WEN LIU; MING YAO; LIANG-IN LIN; WEN-CHIEN CHOU; CHIEN-YU CHEN; HSIN-AN HOU; HWEI-FANG TIEN |
顯示項目 1-10 / 40 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
